fenclonine has been researched along with Diabetes Mellitus in 2 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Excerpt | Relevance | Reference |
---|---|---|
"Both groups of carcinoid patients had a comparable decrease in their insulinogenic index." | 1.25 | Glucose intolerance in the carcinoid syndrome. ( Bivens, CH; Feldman, JM; Lebovitz, HE; Plonk, JW, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feldman, JM | 2 |
Plonk, JW | 2 |
Bivens, CH | 1 |
Lebovitz, HE | 1 |
Admiraal, J | 1 |
Sidbury, JB | 1 |
2 other studies available for fenclonine and Diabetes Mellitus
Article | Year |
---|---|
Glucose intolerance in the carcinoid syndrome.
Topics: Adult; Aged; Carcinoid Tumor; Cyproheptadine; Diabetes Mellitus; Female; Fenclonine; Glucose; Glucos | 1975 |
Plasma amino acids in patients with the carcinoid syndrome.
Topics: Aged; Amino Acids; Diabetes Mellitus; Fenclonine; Humans; Hydroxyindoleacetic Acid; Male; Malignant | 1976 |